- Home
- INVE vs CTOR Comparison
INVE vs CTOR Comparison
Compare INVE & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- CTOR
- Stock Information
- Founded
- INVE 1990
- CTOR 2021
- Country
- INVE United States
- CTOR United States
- Employees
- INVE N/A
- CTOR N/A
- Industry
- INVE Computer peripheral equipment
- CTOR
- Sector
- INVE Technology
- CTOR
- Exchange
- INVE Nasdaq
- CTOR NYSE
- Market Cap
- INVE 82.2M
- CTOR 89.9M
- IPO Year
- INVE 1997
- CTOR N/A
- Fundamental
- Price
- INVE $3.12
- CTOR $0.93
- Analyst Decision
- INVE Strong Buy
- CTOR Strong Buy
- Analyst Count
- INVE 3
- CTOR 2
- Target Price
- INVE $6.83
- CTOR $4.50
- AVG Volume (30 Days)
- INVE 84.3K
- CTOR 3.6M
- Earning Date
- INVE 03-05-2025
- CTOR 05-21-2025
- Dividend Yield
- INVE N/A
- CTOR N/A
- EPS Growth
- INVE N/A
- CTOR N/A
- EPS
- INVE 3.14
- CTOR N/A
- Revenue
- INVE $26,628,000.00
- CTOR N/A
- Revenue This Year
- INVE N/A
- CTOR N/A
- Revenue Next Year
- INVE $40.32
- CTOR N/A
- P/E Ratio
- INVE $1.00
- CTOR N/A
- Revenue Growth
- INVE N/A
- CTOR N/A
- 52 Week Low
- INVE $2.95
- CTOR $0.55
- 52 Week High
- INVE $8.52
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- INVE 40.34
- CTOR N/A
- Support Level
- INVE $3.20
- CTOR N/A
- Resistance Level
- INVE $3.39
- CTOR N/A
- Average True Range (ATR)
- INVE 0.17
- CTOR 0.00
- MACD
- INVE -0.01
- CTOR 0.00
- Stochastic Oscillator
- INVE 21.88
- CTOR 0.00
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.